Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
14-3-3ζ Constrains insulin secretion by regulating mitochondrial function in pancreatic β cells
Yves Mugabo, Cheng Zhao, Ju Jing Tan, Anindya Ghosh, Scott A. Campbell, Evgenia Fadzeyeva, Frédéric Paré, Siew Siew Pan, Maria Galipeau, Julia Ast, Johannes Broichhagen, David J. Hodson, Erin E. Mulvihill, Sophie Petropoulos, Gareth E. Lim
Yves Mugabo, Cheng Zhao, Ju Jing Tan, Anindya Ghosh, Scott A. Campbell, Evgenia Fadzeyeva, Frédéric Paré, Siew Siew Pan, Maria Galipeau, Julia Ast, Johannes Broichhagen, David J. Hodson, Erin E. Mulvihill, Sophie Petropoulos, Gareth E. Lim
View: Text | PDF
Research Article Endocrinology Metabolism

14-3-3ζ Constrains insulin secretion by regulating mitochondrial function in pancreatic β cells

  • Text
  • PDF
Abstract

While critical for neurotransmitter synthesis, 14-3-3 proteins are often assumed to have redundant functions due to their ubiquitous expression, but despite this assumption, various 14-3-3 isoforms have been implicated in regulating metabolism. We previously reported contributions of 14-3-3ζ in β cell function, but these studies were performed in tumor-derived MIN6 cells and systemic KO mice. To further characterize the regulatory roles of 14-3-3ζ in β cell function, we generated β cell–specific 14-3-3ζ–KO mice. Although no effects on β cell mass were detected, potentiated glucose-stimulated insulin secretion (GSIS), mitochondrial function, and ATP synthesis were observed. Deletion of 14-3-3ζ also altered the β cell transcriptome, as genes associated with mitochondrial respiration and oxidative phosphorylation were upregulated. Acute 14-3-3 protein inhibition in mouse and human islets recapitulated the enhancements in GSIS and mitochondrial function, suggesting that 14-3-3ζ is the critical isoform in β cells. In dysfunctional db/db islets and human islets from type 2 diabetic donors, expression of Ywhaz/YWHAZ, the gene encoding 14-3-3ζ, was inversely associated with insulin secretion, and pan–14-3-3 protein inhibition led to enhanced GSIS and mitochondrial function. Taken together, this study demonstrates important regulatory functions of 14-3-3ζ in the regulation of β cell function and provides a deeper understanding of how insulin secretion is controlled in β cells.

Authors

Yves Mugabo, Cheng Zhao, Ju Jing Tan, Anindya Ghosh, Scott A. Campbell, Evgenia Fadzeyeva, Frédéric Paré, Siew Siew Pan, Maria Galipeau, Julia Ast, Johannes Broichhagen, David J. Hodson, Erin E. Mulvihill, Sophie Petropoulos, Gareth E. Lim

×

Figure 3

β Cell–specific deletion of 14-3-3ζ enhances glucose-induced insulin secretion in vivo and increases β cell proliferation.

Options: View larger image (or click on image) Download as PowerPoint
β Cell–specific deletion of 14-3-3ζ enhances glucose-induced insulin sec...
(A) Generation of β cell–specific 14-3-3–KO mice (Cre+ Flox) was accomplished by breeding Ins1CreThor mice with mice harboring floxed alleles of Ywhaz. (B) Isolated mRNA from islets from Cre+ Flox mice and their littermate controls (Cre+ WT) were subjected to qPCR analysis for Ywhaz mRNA levels (n = 3 per genotype; ***P < 0.001) (C) Immunofluorescence staining for insulin and 14-3-3ζ on Cre+ WT and Cre+ Flox pancreatic sections (representative images of n = 3 mice per genotype). Magnification ×20. Scale bar = 100 μm. (D and E) No differences in glucose (D) or insulin (E) tolerance were observed in Cre+ Flox mice following i.p. injections of glucose (2 g/kg) or insulin (0.75 IU/kg), respectively (n = 5–9 mice per genotype). (F and G) Cre+ Flox mice displayed potentiated insulin secretion (F) following i.p. glucose (2 g/kg) injections, and no differences were observed in circulating glucagon (G) (n = 5–9 per genotype; *P < 0.05). (H and I) Pancreatic tissue from 12-week-old Cre+ WT and Cre+ Flox mice were collected, and β cell mass (H) and islet size distribution (I) were determined (n = 5–6 mice, 4 sections per mouse). Scale bar: 800 μm. (J and K) β Cell proliferation was measured by coimmunostaining for PCNA+ (J, n = 3 per genotype; *P < 0.05; scale bar: 100 μm) or Ki-67+ β cells (K, n = 3 per genotype; **P < 0.01; scale bar: 100 μm). White arrows denote positive cells. (L) TUNEL+ apoptotic β cells (white arrows) were measured in 4 pancreatic sections from Cre+ WT and Cre+ Flox mice. Scale bar: 100 μm. White arrows denote positive cells. Significance was determined by unpaired, 2-tailed Student’s t test (B, J, K, and L) or by 2-way ANOVA, followed by Tukey’s multiple-comparison test (F).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts